This page contains brief information about selinexor and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Selinexor is approved to treat:
- Multiple myeloma that has relapsed (come back) or is refractory (does not respond to treatment). It is used with dexamethasone in adults who have received at least four previous treatments that included at least two proteasome inhibitors, at least two immunomodulating agents, and an anti-CD38 monoclonal antibody.
This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that selinexor provides a clinical benefit in these patients.
Selinexor is also being studied in the treatment of other types of cancer.
More About Selinexor
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Selinexor - Check for trials from NCI's list of cancer clinical trials now accepting patients.